German Christopher Paul sold RYTM
March 4, 2026 · Form 4 insider transaction
German Christopher Paul sold 5,614 shares of Rhythm Pharmaceuticals, Inc. at $89.56 per share, a transaction worth $502.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,614
Price
$89.56
Total value
$502.8K
InsiderGerman Christopher Paul
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after160
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 21 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan.